» Articles » PMID: 35066634

Perfusion Measurement in Brain Gliomas Using Velocity-selective Arterial Spin Labeling: Comparison with Pseudo-continuous Arterial Spin Labeling and Dynamic Susceptibility Contrast MRI

Overview
Journal Eur Radiol
Specialty Radiology
Date 2022 Jan 23
PMID 35066634
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate the performance of velocity-selective (VS) ASL among patients with untreated gliomas by comparing with both pseudo-continuous (PC) ASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging (DSC-PWI).

Methods: Forty-four consecutive patients with newly diagnosed glioma who underwent preoperative perfusion MRI including VSASL, PCASL, and DSC-PWI between 2017 and 2019 were retrospectively evaluated. Visual inspection was performed to evaluate the tumor signal intensity relative to gray matter based on 1-5 score criteria and weighted kappa was used to evaluate the pair-wise concordance between VSASL or PCASL and DSC-PWI. The relative tumor blood flow (rTBF) was measured from sampling intra-tumoral areas of hot-spot on the blood flow map and normalized against the contralateral normal gray matter blood flow. Linear regression and Bland-Altman analyses were performed to evaluate the correlation and agreement of rTBF measurements between ASL methods and DSC-PWI. The ROC analysis was constructed to determine the diagnostic performance of three perfusion methods for grading gliomas.

Results: TBF maps derived from VSASL were more comparable with DSC-PWI than PCASL on visual inspection (weighted kappa of 0.90 vs 0.68). In quantitative analysis, VSASL-rTBF yielded higher correlation with the values from DSC-PWI than PCASL-rTBF (R = 80% vs 47%, p < 0.001 for both). Both ASL and DSC-derived rTBF showed good distinction between low-grade and high-grade gliomas (p < 0.001). Compared to PCASL, VSASL yielded superior diagnostic sensitivity, specificity, and accuracy in glioma grading.

Conclusions: VSASL showed great promise for accurate quantification of TBF and could potentially improve the diagnostic performance of ASL in preoperative grading of gliomas.

Key Points: • VSASL demonstrated a greater agreement with DSC-PWI than with PCASL on visual inspection and perfusion quantification. • VSASL showed a higher diagnostic sensitivity, negative predictive value, and accuracy than PCASL for glioma grading. • With the advantages of insensitivity to transit delay and no need of prescribing a labeling plane, VSASL could potentially improve the diagnostic performance of ASL for a more accurate, noninvasive quantification of TBF in patients with glioma.

Citing Articles

Preoperative prediction of diffuse glioma type and grade in adults: a gadolinium-free MRI-based decision tree.

Azizova A, Prysiazhniuk Y, Wamelink I, Cakmak M, Kaya E, Wesseling P Eur Radiol. 2024; 35(3):1242-1254.

PMID: 39425768 PMC: 11836213. DOI: 10.1007/s00330-024-11140-5.


Direct angiographic comparison of different velocity-selective saturation, inversion, and DANTE labeling modules on cerebral arteries.

Liu D, Zhu D, Qin Q Magn Reson Med. 2024; 92(2):761-771.

PMID: 38523590 PMC: 11142876. DOI: 10.1002/mrm.30085.


Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.

Bayraktar E, Duygulu G, Cetinoglu Y, Gelal M, Apaydin M, Ellidokuz H BMC Med Imaging. 2024; 24(1):70.

PMID: 38519901 PMC: 10958956. DOI: 10.1186/s12880-024-01249-w.


Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion.

Lambrecht S, Liu D, Dzaye O, Kamson D, Reis J, Liebig T Brain Sci. 2024; 14(2).

PMID: 38391701 PMC: 10886779. DOI: 10.3390/brainsci14020126.


Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?.

Wamelink I, Azizova A, Booth T, Mutsaerts H, Ogunleye A, Mankad K Radiology. 2024; 310(2):e230793.

PMID: 38319162 PMC: 10902600. DOI: 10.1148/radiol.230793.


References
1.
Ostrom Q, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C . CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017; 19(suppl_5):v1-v88. PMC: 5693142. DOI: 10.1093/neuonc/nox158. View

2.
LaPointe S, Perry A, Butowski N . Primary brain tumours in adults. Lancet. 2018; 392(10145):432-446. DOI: 10.1016/S0140-6736(18)30990-5. View

3.
Folkman J . Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971; 285(21):1182-6. DOI: 10.1056/NEJM197111182852108. View

4.
Jain R, Tomaso E, Duda D, Loeffler J, Sorensen A, Batchelor T . Angiogenesis in brain tumours. Nat Rev Neurosci. 2007; 8(8):610-22. DOI: 10.1038/nrn2175. View

5.
Cha S, Tihan T, Crawford F, Fischbein N, Chang S, Bollen A . Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2005; 26(2):266-73. PMC: 7974081. View